Journal Information
Vol. 43. Issue 2.
Pages 64-72 (February 2007)
Share
Share
Download PDF
More article options
Vol. 43. Issue 2.
Pages 64-72 (February 2007)
Original Article
Full text access
Impact of Chronic Obstructive Pulmonary Disease on Activities of Daily Living: Results of the Multicenter EIME Study
Visits
8122
Francisco Javier Álvarez-Gutiérreza,
Corresponding author
fag01se@saludalia.com

Correspondence: Dr. F.J. Álvarez-Gutiérrez. Alcalde Manuel del Valle, Edificio Cónsul, portal 6, 1.°, A. 41008 Sevilla. España
, Marc Miravitllesb, Miriam Callec, Elena Gobarttd, Francisco Lópeze, Antonio Martínf, the EIME Study Group *
a Servicio de Neumología, Red Respira RTIC 03/11 ISCIII, Hospital Virgen del Rocío, Sevilla. Spain
b Servei de Pneumologia, Institut Clínic del Tòrax (IDIBAPS), Red Respira RTIC 03/11 ISCIII, Hospital Clínic, Barcelona, Spain
c Servicio de Neumología. Red Respira RTIC 03/11 ISCIII, Hospital Clínico San Carlos, Madrid, Spain
d R&D Department, Boehringer Ingelheim, Barcelona, Spain
e Nufarm 21, Madrid, Spain
f R&D Department, Pfizer, Madrid, Spain
This item has received
Article information
Objective

The aim of this study was to determine the impact of chronic obstructive pulmonary disease (COPD) on activities of daily living in a large group of patients in Spain who responded to a specific questionnaire. A second aim was to explore the practical utility of the questionnaire and determine which variables could be used to identify “fragile” patients or patients in greater need of attention. To do this, we examined the relationship between questionnaire results and clinical variables, lung function measurements, socioeconomic status, and validated quality of life questionnaires.

Methods

We conducted an observational, descriptive, multicenter, cross-sectional study in which 227 respiratory specialists from all over Spain collected data from 1057 patients with COPD. Each patient was given a specific questionnaire containing 7 items that measured the extent to which COPD affected different aspects of their lives. The patients rated each item on a scale of 0 to 2, depending on the level of impact. Total possible scores, thus, ranged from 0 to 14, and patients with a score of 9 or higher were classified as fragile. We then explored the relationship between questionnaire results and clinical variables, socioeconomic status, spirometric values, and quality of life as measured by the St George's Respiratory Questionnaire (SGRQ).

Results

We studied 1057 patients (95.2% male) with a mean (SD) age of 67 (9) years and a mean predicted forced expiratory volume in 1 second (FEV1) of 41.8% (13.3%). The mean questionnaire score was 6.3 (3.1). The activities that were affected most were sport and leisure, habitual physical activity, and sex life (major impact reported by 52.5%, 30.3%, and 20.2% of patients, respectively). We found a correlation between questionnaire scores and known disease severity markers such as SGRQ scores, dyspnea, number of exacerbations, and FEV1 in liters. Patients included in the fragile category were older and had a lower socioeconomic status.

Conclusions

COPD impact questionnaire scores correlated well with SGRQ scores and the usual clinical variables and lung function measurements for evaluating disease severity (dyspnea, FEV1, and exacerbations). The questionnaire could, therefore, be a useful tool for identifying fragile patients who, in addition to having poorer clinical status and lung function measurements, have a lower socioeconomic status.

Key words:
Chronic obstructive pulmonary disease
COPD
Health-related quality of life
Fragile patient
Objetivo

Realizamos el estudio con el propósito de conocer, a través de un cuestionario específico, el impacto de la enfermedad pulmonar obstructiva crónica (EPOC) sobre las actividades de la vida diaria en un grupo amplio de pacientes en España. Asimismo estudiamos su relación con parámetros clínicos, funcionales y socioeconómicos, y con escalas validadas de calidad de vida, para evaluar su utilidad en la práctica habitual y determinar qué variables pueden definir a los pacientes “frágiles” o que requieren una mayor atención.

Métodos

Se ha realizado un estudio observacional, descriptivo, multicéntrico y transversal, con la participación de 227 neumólogos de toda España, que incluyó a pacientes con el diagnóstico de EPOC. A todos éstos se les pasó un cuestionario específico con 7 preguntas que medían el impacto de la enfermedad sobre aspectos de la vida diaria Las respuestas se valoraron de 0 a 2, según el grado de afectación, lo que supone un intervalo entre 0 y 14 unidades. Definimos al paciente como “frágil” si presentaba valores iguales o mayores de 9 en el cuestionario de impacto. Se evaluó la relación entre la escala de impacto y variables clínicas, situación socioeconómica, espirometría y calidad de vida medida con el cuestionario específico St. George's Respiratory Questionnaire (SGRQ).

Resultados

Estudiamos a 1.057 pacientes (un 95,2% varones), con una edad media (± desviación estándar) de 67 ± 9 años y volumen espiratorio forzado en el primer segundo (FEV1), expresado en porcentaje, del 41,8 ± 13,3%. La puntuación media del cuestionario de impacto fue de 6,3 ± 3,1. Las actividades con mayor afectación fueron deporte y ocio, actividad física habitual y vida sexual (mucha afectación en el 52,5, el 30,3 y el 20,2% de los pacientes, respectivamente). Encontramos relación entre la puntuación del cuestionario y parámetros conocidos de gravedad (SGRQ, disnea, número de agudizaciones y FEV1 expresado en litros). Los pacientes definidos como frágiles tenían mayor edad y menor nivel tanto cultural como económico.

Conclusiones

El cuestionario de impacto de la EPOC se correlaciona bien con los clásicos parámetros clínicos y funcionales de valoración de la gravedad de la enfermedad (disnea, FEV1 y exacerbaciones) y con el cuestionario de calidad de vida relacionada con la salud SGRQ. Así pues, podría ser un instrumento útil para identificar un perfil de paciente frágil, que presenta, además de una peor situación clínica y funcional, una situación socioeconómica más desfavorecida.

Palabras clave:
EPOC
Calidad de vida relacionada con la salud
Paciente frágil
Full text is only aviable in PDF
REFERENCES
[1]
V Sobradillo, M Miravitlles, R Gabriel, CA Jimenez Ruiz, C Villasante, JF Masa, et al.
Geographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicenter epidemiological study.
Chest, 118 (2000), pp. 981-989
[2]
B Celli, CG Cote, JM Marin, C Casanova, M Montes de Oca, RA Mendez, et al.
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
N Engl JMed, 350 (2004), pp. 1005-1012
[3]
DA Gerardi, L Iovett, ML Benoit-Connors, JZ Readon, RL ZuWallack.
Variables related to increased mortality following outpatient pulmonary rehabilitation.
Eur Respir J, 9 (1996), pp. 431-435
[4]
C Iandbo, E Prescott, P Iange, et al.
Prognosis value of nutritional status in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 1791-1797
[5]
PW Jones, FH Quirk, CM Baveystock, OA Iittlejohns.
Self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
Am Rev Respir Dis, 145 (1992), pp. 1321-1327
[6]
M Ferrer, J Alonso, L Prieto, V Plaza, E Monso, R Marrades, et al.
Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.
Eur Respir J, 9 (1996), pp. 1160-1166
[7]
S Rennard, M Decramer, PMA Calverley, NB Pride, JB Soriano, PA Vermeire, et al.
Impact of COPD in North America and Europe in 2000 subjects perspective of confronting COPD International Survey.
Eur Respir J, 20 (2002), pp. 799-805
[8]
M Miravitlles, M Calle, F Alvarez-Gutierrez, E Gobartt, F Iopez, A Martin, the EIME group.
Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease.
Qual Life Res, 15 (2006), pp. 471-480
[9]
J Roca, A Sanchis, A Agusti-Vidal, F Segarra, D Navajas, R Rodriguez Roisin, et al.
Spirometric reference values from a Mediterranean population.
Bull Eur Physiopatol Respir, 22 (1986), pp. 271-274
[10]
JA Barbera, G Peces Barba, AGN Agusti, JL Izquierdo, E Monso, T Montemayor, et al.
Gufa clinica para el diagnostico y tratamiento de la enfermedad pulmonar obstructiva cronica.
Arch Bronconeumol, 37 (2001), pp. 297-316
[11]
DA Mahler, CK Wells.
Evaluation of clinical methods for rating dyspnea.
Chest, 93 (1998), pp. 580-586
[12]
C Esteban, J Moraza, M Aburto, JM Quintana, A Capelastegui.
Description de una muestra de pacientes con enfermedad pulmonar obstructiva cronica atendidos en las consultas del area de neumologia dependientes de un hospital.
Arch Bronconeumol, 39 (2003), pp. 485-490
[13]
J de Miguel Dfez, JL Izquierdo Alonso, JM Rodriguez Gonzalez-Moro, P de Lucas Ramos, JM Bellon Cano, J Molina Paris.
Calidad de vida en la enfermedad pulmonar obstructiva cronica. Influencia del nivel de asistencia de los pacientes.
Arch Bronconeumol, 40 (2004), pp. 431-437
[14]
E Skwarska, G Cohen, C Skwarski, C Iamb, D Bushell, S Parker, et al.
Randomised controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease.
Thorax, 55 (2000), pp. 907-912
[15]
F de la Iglesia Martinez, R de la Fuente Cid, V Ramos Polledo, C Pellicer Vazquez, R Nicolas Miguel, F Diz-Lois Martinez.
Analisis factorial de la calidad de vida relacionada con la salud de los pacientes con enfermedad pulmonar obstructiva cronica estable.
Arch Bronconeumol, 37 (2001), pp. 410-416
[16]
AJ McSweeny, I Grant, RK Heaton, KM Adams, RM Timms.
Life quality of patients with chronic obstructive pulmonary disease.
Arch Intern Med, 142 (1982), pp. 473-478
[17]
JC Bestall, EA Paul, R Garrod, R Garnaham, PW Jones, JA Wedzicha.
Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
Thorax, 54 (1999), pp. 581-586
[18]
JM Marin.
Manifestaciones clinicas: la disnea y su importancia en el paciente con EPOC.
Arch Bronconeumol, 37 (2001), pp. 8-13
[19]
R Garrod, JC Bestall, EA Paul, JA Wedzicha, PW Jones.
Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living Scale (LCADL).
Respir Med, 94 (2000), pp. 589-596
[20]
PW Jones.
Health status measurement in chronic obstructive pulmonary disease.
Thorax, 1956 (2001), pp. 880-887
[21]
M Ferrer, C Villasante, J Alonso, V Sobradillo, R Gabriel, G Vilagut, et al.
General population norms of the St George's respiratory questionnaire: a strategy to facilitate interpretation of quality of life scores.
Eur Respir J, 19 (2002), pp. 405-413

The researchers that formed part of the EIME Study Group are listed at the end of the article.

The EIME study was funded by Boehringer Ingelheim and Pfizer.

Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?